August 28, 2001

NeoSurg Technologies, Inc. Receives U.S. Patent
for T2000 Reusable Trocar Access System

Houston, TX August 28, 2001 - NeoSurg Technologies, Inc., a leading developer of minimally invasive access products for laparoscopic surgery, is pleased to announce that it has been granted a patent relating to its trocar technology. The patent, U.S. No. 6,280,417, titled "Trocar" covers the locking mechanism for the obturator shield on its trocar system, the T2000 Reusable Trocar System.

"This locking technology will allow the surgeon to maintain activation button contact during insertion or release it based on their preference, said Pete O’Heeron, President/CEO of NeoSurg Technologies, Inc. This patent should give us additional support in our efforts to bring advanced locking features to the market in an effort to protect the tip during insertion.”

NeoSurg owns patents and has numerous pending patent applications for the minimally invasive access market—showing a strong patent position and commitment to developing clinically sophisticated and cost effective solutions. The objective of the patents is to broaden the intellectual property protection worldwide for the T2000 Technology.”

Currently, NeoSurg Technology is protected by over 13 patents and patent applications worldwide.

About the T2000 System
The T2000 System consists of a Reusable Trocar constructed of titanium and hard anodized aluminum for durability and reliability. The access tip is disposable which provides the surgeon with a consistently sharp and controlled penetration. A locking shielding mechanism is attached to the main trocar to guard the tip during insertion.

About NeoSurg Technologies
NeoSurg Technologies, Inc., based in Houston, Texas, is a privately held medical device company focused on bringing breakthrough products for minimally invasive surgery to market. These products are based on the Company’s patented technology, which allows the combination of disposable components with reusable components in a sophisticated and reliable system.

For more information on NeoSurg Technologies, Inc. visit the company Website at www.neosurg.com or contact:

Pete O’Heeron
President and Chief Executive Officer
(281) 461-6211
poheeron@neosurg.com

Certain statements made by the Company which are not historical facts may be considered forward-looking statements, including, and without limitation, statements as to trends, management’s beliefs, expectations and opinions, which are based upon a number of assumptions concerning future conditions that ultimately may prove to be inaccurate. Such forward-looking statements are subject to risks and uncertainties and may be affected by various factors, which may cause actual results to differ materially from those forward-looking statements.

.